Hailey Cambra
Gene Editing Research Scientist Vertex Pharmaceuticals
Seminars
Thursday 30th April 2026
Strategizing Model Selection Across Preclinical Development Stages to Maximize Efficiency & Scientific Impact
3:00 pm
- Explaining why complex in vitro models aren't used for screening due to time constraints and model limitations to enable faster decision-making
- Deploying complex three-dimensional models strategically for mechanistic studies to gain deeper biological insights where complexity adds value
- Selecting simpler and faster model systems for other development stages to balance throughput needs with appropriate biological relevance
Wednesday 29th April 2026
Panel Discussion: Planning Ahead for CIVM Development to Ensure Models Are Ready for Critical Research Questions
3:45 pm
- Anticipating future research needs early to reduce delays and accelerate model implementation when questions arise
- Evaluating existing platforms versus new models to minimize cost and time while maintaining scientific rigor
- Engaging senior leadership in proactive planning to align resources and timelines for complex model development
